Acadia Pharmaceuticals Inc (ACAD): Cash & Equivalents
$177.69M
As of 2025-12-31
$384.99M
As of 2026-06-30
+15.7%
3-year compound annual growth
-11.4%
5-year compound annual growth
+5.7%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $177.69M | -44.4% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $319.59M | +69.4% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $188.66M | +64.3% | 2026-02-26, Balance as of period end |
| 2022-12-31 | $114.85M | -22.1% | 2025-02-27, Balance as of period end |
| 2021-12-31 | $147.44M | -54.8% | 2024-02-28, Balance as of period end |
| 2020-12-31 | $326.03M | +71.9% | 2023-02-28, Balance as of period end |
| 2019-12-31 | $189.68M | +40.8% | 2022-03-01, Balance as of period end |
| 2018-12-31 | $134.76M | +94.1% | 2021-02-25, Balance as of period end |
| 2017-12-31 | $69.42M | -57.6% | 2020-02-27, Balance as of period end |
| 2016-12-31 | $163.62M | +60.2% | 2019-02-27, Balance as of period end |
| 2015-12-31 | $102.14M | +65.1% | 2018-02-27, Balance as of period end |
| 2014-12-31 | $61.85M | +428.4% | 2017-02-28, Balance as of period end |
| 2013-12-31 | $11.71M | -79.8% | 2016-02-29, Balance as of period end |
| 2012-12-31 | $57.90M | +740.5% | 2015-02-26, Balance as of period end |
| 2011-12-31 | $6.89M | +0.6% | 2014-02-27, Balance as of period end |
| 2010-12-31 | $6.85M | -62.2% | 2013-03-12, Balance as of period end |
| 2009-12-31 | $18.12M | n/a | 2012-03-06, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $177.69M | -44.4% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $63.87M | -34.8% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $198.69M | +98.7% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $372.26M | +53.8% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $195.00M | -38.9% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $285.58M | +97.1% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $752.50M | +66.1% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $231.25M | +227.7% |
| Alkermes plc. (ALKS) | 2025-12-31 | $388.57M | +33.5% |
Compare ACAD, PBH, MDGL, IONS side by side · Screen every company in Pharmaceutical Preparations ↗